Exact Mass: 360.2413
Exact Mass Matches: 360.2413
Found 500 metabolites which its exact mass value is equals to given mass value 360.2413
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Calycanthidine
Calycanthidine is found in herbs and spices. Calycanthidine is an alkaloid from the seeds of Calycanthus floridus (Carolina allspice
17-hydroxy-hexahydro-cur-19-ene-16-carboxylic acid methyl ester|Preakuammicin
ent-7alpha-acetoxy-14beta-hydroxykaur-16-en-15-one
(ent-15beta)-Ac-15-Hydroxy-16-kauren-19-oic acid|Ac-15-Hydroxy-16-kauren-19-oic acid|ent-1alpha-acetoxy-kaurenic acid
5-methoxy-3-(8Z,11Z)-pentadeca-8,11,14-trienylbenzene-1,2,4-triol|5-methoxy-3-<(8Z,11Z)-pentadeca-8,11,14-trienyl>benzene-1,2,4-triol
(2E,4E,9Z)-octadecatrien-6-yne-1,18-diyl diacetate
2-??-Acetoxy-cis-cleroda-3,13(Z),8(17)-trien-15-oic acid
(13Z)-5-acetoxy-12-hydroxy-4,10-secospata-2,13(15),17-trien-10-one
1-Phenanthrenecarboxylicacid,5-(acetyloxy)-7-ethenyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a,7-trimethyl-,(1R,4aS,4bS,5R,7R,10aR)-
ent-12alpha-acetoxypimar-9(11),15-dien-19-oic acid
ent-7beta-acetoxy-11alpha-hydroxykaur-16-en-15-one|ent-7??-Acetoxy-11??-hydroxykaur-16-en-15-one
4-acetoxy-4-methoxy-2-(3,6,9-tetradecatrienyl)-2-cyclopenten-1-one
(4Z,8S,9R,12E,14E)-1-isopropyl-8,12-dimethyl-18-oxo-oxabicyclo[9.3.2]-hexadeca-4,12,14-trien-2-yl acetate
(5R,7R,10S)-3-oxo-7,12-dimethoxyabieta-8,11,13-trien-11-ol
ent-6beta-acetoxy-labda-7,12E,14-triene-17-oic acid
7-Ac-(ent-7alpha)-6-Hydroxy-16-Kauren-19-oic acid|7beta-acetoxy (-)-kaur-16-en-19-oic acid|7beta-acetoxy-(-)-kaur-16-en-19-oic acid|7beta-acetoxy-ent-kaur-16-en-19-oic acid
Ac-6-Hydroxy-3,12,14-clerodatrien-20-oic acid|heteroscyphic acid B
18-Hydroxyaustrochaparolacetat|7-Ac-(ent-7alpha)-15,16-Epoxy-8(17),13(16),14-labdatriene-7,18-diol
19-acetoxy-8(17),13-ent-labdadien-15->16 lactone|andrograpanin acetate
3beta-hydroxy-19-O-acetyl-pimara-8(9),15-dien-7-one
Ac-7, 8-Epoxy-6-hydroxy-3, 12(18),-dolabelladien-13-one
5alpha-Methoxy-5,10-dihydroprintziasaeure-methylester
9-(3,4-dihydro-6-hydroxy-2R,8-dimethyl-2H-1-benzopyran-2-yl)-2,6-dimethyl-(6E)-nonenoic acid
ent-11alpha-acetoxy-7beta-hydroxykaur-16-en-15-one
(2S,7S,8S,13S,3E,11E)-13-acetoxy-7,8-epoxycembra-3,11-diene|13-acetoxysarcophytoxide
4-(2-(2,5,5,8a-Tetramethyl-4-acetoxydecalin-1-ene-1-yl)ethyl)furan-2(5H)-one
1beta-hydroxy-7beta-acetoxy-ent-pimara-8,15-dien-14-one|7-O-acetylpedinophyllol E
1-O-acetyl-2-O-[(R)-3-hydroxytetradecanoyl]-sn-glycerol
3beta-acetoxy-19-nor-10beta-hydroperoxypregn-20-ene|sclerosteroid E
(4S)-3,4-seco-4,21-dihydroxy-4-methyl-20-oxo-5alpha-pregna-8-en-3-oic acid epsilon-lactone|nodulisporisteriod A
(+)-(1S,4R,5S,10S,13S)-1,18-dihydroxyabieta-7,9(11)-diene-12-one 1-monoacetate|inflexanin D
(2S)-lactyl (E)-17-methyl-9-octadecen-5,7-diynoate|heterofibrin B2
9alpha-acetoxy-3alpha-hydroxy-1(15),8(19)-trinervitadien-8-one|9alpha-acetoxy-3alpha-hydroxy-2-oxo-1(15),8(19)-trinervitadiene
Ac-(1E,3E,7R*,8R*,11S*,12S*,14R*)-7,8:11,12-Diepoxy-1,3,15-cembratrien-14-ol
ent-20-acetoxy-11alpha-hydroxy-16-kauren-15-one|ent-20-Acetoxy-11??-hydroxy-16-kauren-15-one
(4R,9S,13Z)-12-acetoxy-4-hydroxy-4,10-secospata-2,13(15),17-trien-10-one
2beta-Acetoxy-(3beta,7beta)-3-Hydddroxy-8-kempen-6-one
(6S)-4,6-dimethyldodecadien-2E,4E-dienoyl ester of phomalactone
12-Ac-4,12-Dihydroxy-4,10-seco-2,13(15),17-spatatrien-10-one
7-Hydrxoy-5-Hydroxy-2-tridecyl-4H-1-benzopyran-4-one
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17beta)-
13-Ac-(5alpha,8beta,9beta,12beta,13beta,14beta)-9,13-Dihydroxy-1,3-dolastadien-6-one
2-hydroxy-5-methoxy-3-[8Z,11Z-pentadecadiene]-p-benzoquinone|sorgoleone-360
6beta-acetoxy-9alpha,13-epoxy-labda-7,14-dien-17-al
11beta-acetoxyspongi-12-en-16-one|11beta-hydroxyspongi-12-en-16-one
3R*-acetoxy-7R*,8R*-epoxy-13-keto-1R*,11S*-dolabell-4(16),12(18)-diene
6,7-dihydro-7-hydroxy-7-methyl-6-(2-oxononyl)-3-[(E)-prop-1-enyl]-1H-isochromen-8(5H)-one|monaphilone A
3beta-senecioyloxy-6beta-ethoxy-10beta-H-furanoeremophilane
(1Z,3E,7E,11E)-14-acetoxycembra-1,3,7,11-tetraene-9,10-diol
4-acetoxymethyl-7-senecioyloxy-1,2,6,10-tetramethylbicyclo-<4.4.0>deca-2,9-diene|4-acetoxymethyl-7-senecioyloxy-1,2,6,10-tetramethylbicyclo-[4.4.0]deca-2,9-diene
C22H32O4_12-Acetoxypimara-7,15-dien-18-oic acid
6-acetyloxy-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid
(1R,5R,9S,15S)-15-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
Resolvin D5
A member of the class of resolvins that is (4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying two hydroxy substituents at positions 7 and 17 (the 7S,17S-stereoisomer). CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0212.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0212.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0212.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000143.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
Maresin 1
CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001319.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
(1R,5R,9S,15S)-15-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid_major
(1R,5R,9S,15S)-15-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid_95.4\\%
(1R,5R,9S,15S)-15-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid_48.6\\%
7,9,13,17-tetramethyl-7S,14S-dihydroxy-2E,4E,8E,10E,12E,16-octadecahexaenoic acid
Resolvin D6
A member of the class of resolvins that is (5E,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying two hydroxy substituents at positions 4 and 17 (the 4S,17S-stereoisomer).
Iloprost
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C78568 - Prostaglandin Analogue C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Macrophorin A
Protectin D1
A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13E,15Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10R,17S-stereoisomer). Protectin D1 is one of the specialised proresolving mediators. When produced in neural tissues, it is called neuroprotectin D1
ascr#22
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (12R)-12-hydroxytridecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#22
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 13-hydroxytridecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
TRANS-1-(2-(4-(4-BUTYLCYCLOHEXYL)PHENYL)ETHYNYL)-4-ETHOXYBENZENE
Silandrone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
1-propoxy-4-[2-[4-(4-propylcyclohexyl)phenyl]ethynyl]benzene
TRANS-1-(2-(4-METHOXYPHENYL)ETHYNYL)-4-(4-PENTYLCYCLOHEXYL)BENZENE
4-ethyl-2-methylideneoctanoic acid,prop-2-enoic acid,styrene
Istaroxime
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent
(12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridecanoic acid
13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridecanoic acid
10(R),17(R)-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)-7,17-Dihydroxydocosa-4,8,10,13,15,19-hexaenoic acid
11beta,17beta-Dihydroxyandrost-4-en-3-one 17-propionate
Cannabinerolic acid
A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a neryl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant.
9alpha-Hydroxy-3-oxo-23,24-bisnorchol-4-en-22-oic acid
(2S)-2-[(8R,9S,10R,12S,13S,14S,17R)-12-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]propanoic acid
(4E,7E,11E,13E,15E,19E)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid
(4Z,7Z,9E,13Z,16Z,19Z)-11-Hydroperoxydocosahexaenoic acid
(4E,8E,10E,12E,16E,19E)-7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid
[3-Carboxy-2-(10-carboxydecanoyloxy)propyl]-trimethylazanium
dilopholide
A diterpenoid isolated from the brown alga Dilophus ligulatus and has been shown to exhibit cytotoxic activity.
(4Z,7S,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid
(1R,4S,5R,9S,10S,13R,15S)-15-acetyloxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid
(4S,5E,7Z,10Z,13Z,15E,17R,19Z)-4,17-dihydroxydocosa-5,7,10,13,15,19-hexaenoic Acid
yanuthone X2
A class II yanuthone that is 5,6-epoxy-cyclohex-2-en-1-one which is substituted at positions 3, 4, and 6 by methoxy, hydroxy, and trans,trans-farnesyl groups, respectively (the 4S,5R,6R stereoisomer). Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 51.7 +-4.7 muM).
4-[[4-Cyclohexyl-3-(2-hydroxyethyl)-1-piperazinyl]methyl]benzoic acid methyl ester
(1R,5R,6R)-5-hydroxy-1-[(2E,6E,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-methyl-7-oxabicyclo[4.1.0]hept-3-en-2-one
6-{3-[(1E,3E,5Z,7E,11Z)-9-hydroxytetradeca-1,3,5,7,11-pentaen-1-yl]oxiran-2-yl}hexanoic acid
(5Z)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
(4Z,7S,8E,10Z,12E,14S,16Z,19Z)-7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid
(5Z)-5-[(3As,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
3-(17-Hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)propanoic acid
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroperoxydocosa-4,8,10,13,16,19-hexaenoic acid
[(2R)-3-carboxy-2-(10-carboxydecanoyloxy)propyl]-trimethylazanium
(4Z,7S,8E,10Z,13Z,16Z,19Z)-7-hydroperoxydocosa-4,8,10,13,16,19-hexaenoic acid
(4Z,7Z,9E,11S,13Z,16Z,19Z)-11-hydroperoxydocosa-4,7,9,13,16,19-hexaenoic acid
2-Trimethylsilyloxylauric acid trimethylsilyl ester
2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxyacetic acid
17R-hydroperoxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid
(4Z,7Z,11E,13Z,16Z,19Z)-10-Hydroperoxydocosahexaenoic acid
(13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 13R- and 14S-positions.
10S,17S-dihydroxy-4Z,7Z,11E,13Z,15E,19Z-docosahexaenoic acid
aspirin-triggered protectin D1
A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13E,15Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10R,17R-stereoisomer).
(4Z,7Z,10Z,12E,14S,16Z,19Z,21S)-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14S- and 21S-positions.
(4Z,7Z,10Z,12E,14R,16Z,19Z,21S)-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14R- and 21S-positions.
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14S- and 21R-positions.
14(S)-HPDHE
A hydroperoxy fatty acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the hydroperoxy group is located at the 14(S)-position.
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14S- and 22-positions.
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14R- and 22-positions.
(4Z,8E,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosahexaenoic acid
A hydroperoxy fatty acid that is (4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the hydroperoxy group is located at position 14S. An intermediate of specialised proresolving mediators
7,8-epoxy,17-hydroxy-(9E,11E,13Z,15E,19Z)-docosapentaenoic acid
A docosanoid that is (9E,11E,13Z,15E,19Z)-docosapentaenoic acid carrying an epoxy group across positions 7 and 8 as well as a hydroxy substituent at position 17. An intermediate of specialised proresolving mediators.
(7S,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 7S- and 14S-positions.
(7S,14S)-dihydroxy-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 7S- and 14S-positions.
(4Z,7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosahexaenoic acid
A docosanoid that is (4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying a hydroperoxy substituent at position 17S.
(4Z,7Z,10Z,12E,14R,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14R- and 21R-positions.
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 7R- and 14S-positions.
aspirin-triggered resolvin D5
A member of the class of resolvins that is (5Z,8E,10Z,13Z,15Z,19Z)-docosahexaenoic acid carrying two hydroxy substituents at positions 7 and 17 (the 7S,17R-stereoisomer).
aspirin-triggered resolvin D6
A member of the class of resolvins that is (5E,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying two hydroxy substituents at positions 4 and 17 (the 4S,17R-stereoisomer).
(4Z,7Z,10S,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosahexaenoic acid
A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13Z,15E,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10S,17S-stereoisomer). A natural isomer of protectin D1, one of the specialised proresolving mediators.
yanuthone F
A class I yanuthone that is 7-deacetoxyyanuthone A in which one of the hydrogens of the trans-terminal methyl groups of the sesquiterpenoid side-chain has been replaced by a hydroxy group.
4a-hydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
10-ethoxy-3-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-1,4-dione
8-[2-(furan-3-yl)ethyl]-4,4a,7,8-tetramethyl-3-oxo-hexahydro-1h-naphthalen-2-yl acetate
[(1r,4as,5r,8as)-1,4a-dimethyl-6-methylidene-5-[2-(2-oxo-5h-furan-3-yl)ethyl]-hexahydro-2h-naphthalen-1-yl]methyl acetate
2-{5,9-dimethyl-15-oxo-14-oxabicyclo[11.2.1]hexadeca-1(16),4,8-trien-12-yl}propan-2-yl acetate
(3r,6r,7s,11s,13r)-13-hydroxy-11-methoxy-3-methyl-6-(6-methylhepta-1,5-dien-2-yl)-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one
(1r,2s,4as,7r,8r,8as)-7,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl benzoate
11-hydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,3z,5r,7s,10z,12s,13s,14s)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
5-oxo-4-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-2h-furan-2-yl acetate
(1s,4s,5s,9r,10r,11r,13r)-11-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(4bs,8as,10r)-10-ethoxy-3-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-1,4-dione
(1s,4ar,5s,8s,8as)-8-(acetyloxy)-1,4a-dimethyl-6-methylidene-5-[(2z)-3-methylpenta-2,4-dien-1-yl]-hexahydro-2h-naphthalene-1-carboxylic acid
8-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(5r)-3-[(1e)-2-[(1s,4r,4as,8ar)-4-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl]-5-ethoxy-5h-furan-2-one
2-(acetyloxy)-1,4a-dimethyl-6-methylidene-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carboxylic acid
{11-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methyl acetate
5-hydroxy-4-(hydroxymethyl)-1-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(2s,4s,4ar,8s,8as)-4-[2-(furan-3-yl)ethyl]-8-(hydroxymethyl)-4a,8-dimethyl-3-methylidene-hexahydro-1h-naphthalen-2-yl acetate
11-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(1r,2s,4r,5s,9s,10r,12r,13r,14s)-2-(acetyloxy)-5,9,13-trimethylpentacyclo[11.2.1.0¹,¹⁰.0⁴,⁹.0¹²,¹⁴]hexadecane-5-carboxylic acid
[(1z,5e,8r,11s)-6-methyl-11-[(2s)-6-methylhept-5-en-2-yl]-10-oxo-9-oxabicyclo[6.2.1]undeca-1,5-dien-2-yl]methyl acetate
[(1r,2s,4s,5s,9r,10s,13r)-2-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
(1r,5r,6r)-1-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-hydroxy-4-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(1s,2r,6r,7s,10r,12s,13s,14r,15r)-15-(acetyloxy)-2,6,12-trimethylpentacyclo[11.2.1.0¹,¹⁰.0²,⁷.0¹²,¹⁴]hexadecane-6-carboxylic acid
3,10-dihydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-9-yl acetate
(1s,10s,10as)-7-methyl-10-[(2r)-6-methylhept-5-en-2-yl]-3-oxo-1h,5h,8h,9h,10h,10ah-cyclonona[c]furan-1-yl acetate
(4as,5r,6ar,7s,11ar,11bs)-4a-hydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
(1s,2s,3r,6s,9r,10r,11r,12s)-6,9-dihydroxy-2-octyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-diene-7-carboxylic acid
3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4,6-dihydroxy-2-pentylbenzoic acid
methyl (4ar,5s,6r,8as)-5-[2-(furan-3-yl)ethyl]-8a-(methoxymethyl)-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
(1s,3ar,4r,7ar)-7,7a-diformyl-3a-methyl-1-[(2s)-6-methylhept-5-en-2-yl]-2,3,4,5-tetrahydro-1h-inden-4-yl acetate
4-ethoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl 3-methylbut-2-enoate
(1s,4r,5r,9s,10r,12s,13r)-12-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
methyl 5-[2-(furan-3-yl)ethyl]-8a-(methoxymethyl)-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
(4s,4as,8as)-4-hydroxy-4-(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1h-naphthalen-1-yl (2e,4e,6e)-octa-2,4,6-trienoate
(1r,2r,5r,6s)-5-hydroxy-1-methyl-2-[(1e,3e,5r,7e,9e,11s)-5,7,11-trimethyltrideca-1,3,7,9-tetraen-1-yl]-3,7-dioxabicyclo[4.1.0]heptan-4-one
[(3r)-3-[(2s,5e)-6,10-dimethyl-1-oxoundeca-5,9-dien-2-yl]-2-formylcyclopent-1-en-1-yl]methyl acetate
5-methyl-8-(6-methylhept-5-en-2-yl)-12-oxo-11-oxatricyclo[7.3.0.0²,⁴]dodec-1(9)-en-7-yl acetate
(1r,5s,6r)-5-hydroxy-4-methoxy-1-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(1r,4as,8as)-3,4a,8,8-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,5,6,7,8a-hexahydronaphthalen-1-yl acetate
(2s,5r,7r,8s)-5-methyl-8-[(2r)-6-methylhept-5-en-2-yl]-12-oxo-11-oxatricyclo[7.3.0.0²,⁴]dodec-1(9)-en-7-yl acetate
(1s,4s,5r,9s,10r,12s,13r)-12-(acetyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
[(1r,4ar,5r,8ar)-5-[2-(furan-3-yl)ethyl]-4a-(hydroxymethyl)-1-methyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl acetate
14-formyl-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl acetate
(2s,6s)-6-[(1s,2r,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-4-formyl-3,6-dihydro-2h-pyran-2-yl acetate
5-hydroxy-1-methyl-2-(5,7,11-trimethyltrideca-1,3,7,9-tetraen-1-yl)-3,7-dioxabicyclo[4.1.0]heptan-4-one
11-(acetyloxy)-5,9-dimethyl-13-methylidenetetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(1s,4s,4ar,8as)-4-(acetyloxy)-5,5,8a-trimethyl-1-[(2e)-3-methylpenta-2,4-dien-1-yl]-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid
14-acetylumbrosin b
{"Ingredient_id": "HBIN001360","Ingredient_name": "14-acetylumbrosin b","Alias": "NA","Ingredient_formula": "C22H32O4","Ingredient_Smile": "CC(=O)OC1CC2C(CCCC2(C3C14C(C(CC3)C(=C)C4=O)O)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
17-acetoxymulin-11,13-dien-20-oicacid
{"Ingredient_id": "HBIN001983","Ingredient_name": "17-acetoxymulin-11,13-dien-20-oicacid","Alias": "NA","Ingredient_formula": "C22H32O4","Ingredient_Smile": "CC1=CCC2(CCC3(C(C2C=C1)CCC3C(C)C)C(=O)O)COC(=O)C","Ingredient_weight": "360.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "261","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "9975806","DrugBank_id": "NA"}
17-hydroxy-11-desoxy-corticosterone
{"Ingredient_id": "HBIN002049","Ingredient_name": "17-hydroxy-11-desoxy-corticosterone","Alias": "NA","Ingredient_formula": "C22H32O4","Ingredient_Smile": "CC12CCC(=O)C=C1CCC3C2CCC4(C3(CCC4(C(=O)CO)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31179","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-acetoxy-7α-hydroxykaur-16-en-15-one
{"Ingredient_id": "HBIN002086","Ingredient_name": "18-acetoxy-7\u03b1-hydroxykaur-16-en-15-one","Alias": "NA","Ingredient_formula": "C22H32O4","Ingredient_Smile": "CC(=O)OCC1(CCCC2(C1CC(C34C2CCC(C3)C(=C)C4=O)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "222","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acetylsventenic acid
{"Ingredient_id": "HBIN014501","Ingredient_name": "acetylsventenic acid","Alias": "acetylsventenicacid","Ingredient_formula": "C22H32O4","Ingredient_Smile": "CC(=O)OC1CC2C(CCCC2(C)C(=O)O)(C3C14CC(CC3)C(=C)C4)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39124;32397","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}